Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinbei oral liquid in idiopathic pulmonary fibrosis
ChiCTR2000035351Phase 4Completed
- Sponsor
- Shandong Provincial Hospital Affiliated to Shandong First Medical University
- Start
- Jul 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Jinbei oral liquid in idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by Shandong Provincial Hospital Affiliated to Shandong First Medical University. Primary endpoints: Acute exacerbation events, Time without disease progression and 5 more. Started Jul 2020; status: completed.
02
Drugs
Jinbei oral liquid
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on ChiCTR2000035351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035351.